News

Maxwellia announces funding to accelerate its mission for Self Care

Alderley Park, UK, 26 March 2018 – Maxwellia, a pioneering ‘prescription to over the counter’ medicines company, today announced that it has raised £700,000 in early-stage investment from the GM&C Life Sciences Fun...

Renephra Secures Investment from Deepbridge Capital and Catapult Ventures

Manchester UK, 21st March 2018 - Renephra, a medical device company, today announced that it has raised £231,000 from Deepbridge Capital and the GM&C Life Sciences Fund, managed by Catapult Ventures. Renephra, spun out of The Unive...

Cytox awarded new Innovate UK funding for Alzheimer’s disease testing

8 March 2018: Oxford & Manchester, UK. Cytox, an emerging precision medicine leader providing genetic testing for Alzheimer’s disease, is pleased to announce that, in partnership with Cardiff University, the company has been awarded fund...

Manchester Imaging Raises £600k to Launch Dental Diagnostic Software

Manchester, UK, 1st February 2018 - Manchester Imaging, a dental diagnostic software company, today announced that it has raised a £600,000 investment from the GM&C Life Sciences Fund, managed by Catapult Ventures, and NPIF - Mercia Equi...

Acea Health announces funding from Catapult Ventures and PUBLIC to launch innovative digital dental and medical consent platform - Flynotes

Alderley Park, UK – 24th January 2018. Acea Health, a digital healthcare company, today announced the completion of a seed funding round to launch Flynotes – its new digital consent platform. The funding comes from the GM&C Life Sc...

From our portfolio

Blueberry Therapeutics

Biotechnology

viewview our portfolio

Our Team

Nick Wright

CEO

view complete team

Contact us

Alderley Park
Alderley Edge
Cheshire
SK10 4TG

Tel: 01625 344300

email